Johnson & Johnson: Myocardial Infarction trials

The registry lists 17 Myocardial Infarction studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 8 have results posted.

Phase 3 5No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)CompletedNCT05966662Not applicableResults posted
• Disrupt CAD III Post-Approval Study (PAS)CompletedNCT05021757Results posted
• Disrupt CAD IV With the Shockwave Coronary IVL SystemCompletedNCT04151628Not applicableResults posted
• Disrupt CAD III With the Shockwave Coronary IVL SystemCompletedNCT03595176Not applicableResults posted
• A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart FailureCompletedNCT01877915Phase 3Results posted
• MINI-AMI: Minimizing Infarct Size With Impella 2.5 Following PCI for Acute Myocardial InfarctionTerminatedNCT01319760Not applicableResults posted
• An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary SyndromeCompletedNCT00809965Phase 3Results posted
• A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse)CompletedNCT00046228Phase 3Results posted
• The RECOVER IV TrialTerminatedNCT05506449Not applicable
• Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular FunctionActive, not recruitingNCT04763200Not applicable
• VITROS Immunodiagnostic Products hs Troponin IStatus unknownNCT03581578
• Door To Unloading With IMPELLA CP System in Acute Myocardial Infarction - Safety and Feasibility StudyCompletedNCT03000270Not applicable
• A Study of Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and ImplicationsCompletedNCT02830178
• Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic InstabilityTerminatedNCT00972270Phase 3
• Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.CompletedNCT00511784
• A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth ControlCompletedNCT00377988
• A Study of Short-Term Outcomes and Economic Impact For Patients With Worsening Congestive Heart Failure When Natrecor (Nesiritide) is Added to Standard-Care Therapy, Compared to Administration of Placebo With Standard-Care TherapyCompletedNCT00270387Phase 3